Hazen S L, Zhang R, Shen Z, Wu W, Podrez E A, MacPherson J C, Schmitt D, Mitra S N, Mukhopadhyay C, Chen Y, Cohen P A, Hoff H F, Abu-Soud H M
Department of Cell Biology, Department of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA.
Circ Res. 1999 Nov 12;85(10):950-8. doi: 10.1161/01.res.85.10.950.
Protein nitration and lipid peroxidation are implicated in the pathogenesis of atherosclerosis; however, neither the cellular mediators nor the reaction pathways for these events in vivo are established. In the present study, we examined the chemical pathways available to monocytes for generating reactive nitrogen species and explored their potential contribution to the protein nitration and lipid peroxidation of biological targets. Isolated human monocytes activated in media containing physiologically relevant levels of nitrite (NO(2)(-)), a major end product of nitric oxide (()NO) metabolism, nitrate apolipoprotein B-100 tyrosine residues and initiate LDL lipid peroxidation. LDL nitration (assessed by gas chromatography-mass spectrometry quantification of nitrotyrosine) and lipid peroxidation (assessed by high-performance liquid chromatography with online tandem mass spectrometric quantification of distinct products) required cell activation and NO(2)(-); occurred in the presence of metal chelators, superoxide dismutase (SOD), and scavengers of hypohalous acids; and was blocked by myeloperoxidase (MPO) inhibitors and catalase. Monocytes activated in the presence of the exogenous ()NO generator PAPA NONOate (Z-[N-(3-aminopropyl)-N-(n-propyl)amino]diazen-1-ium-1,2- diolate) promoted LDL protein nitration and lipid peroxidation by a combination of pathways. At low rates of ()NO flux, both protein nitration and lipid peroxidation were inhibited by catalase and peroxidase inhibitors but not SOD, suggesting a role for MPO. As rates of ()NO flux increased, both nitrotyrosine formation and 9-hydroxy-10,12-octadecadienoate/9-hydroperoxy-10,12-octadecadieno ic acid production by monocytes became insensitive to the presence of catalase or peroxidase inhibitors, but they were increasingly inhibited by SOD and methionine, suggesting a role for peroxynitrite. Collectively, these results demonstrate that monocytes use distinct mechanisms for generating (*)NO-derived oxidants, and they identify MPO as a source of nitrating intermediates in monocytes.
蛋白质硝化和脂质过氧化与动脉粥样硬化的发病机制有关;然而,体内这些事件的细胞介质和反应途径均未明确。在本研究中,我们研究了单核细胞产生活性氮物质的化学途径,并探讨了它们对生物靶点蛋白质硝化和脂质过氧化的潜在作用。分离的人类单核细胞在含有生理相关水平亚硝酸盐(NO₂⁻)的培养基中被激活,亚硝酸盐是一氧化氮(·NO)代谢的主要终产物,它会使载脂蛋白B - 100的酪氨酸残基硝化,并引发低密度脂蛋白(LDL)脂质过氧化。LDL硝化(通过气相色谱 - 质谱法定量硝基酪氨酸评估)和脂质过氧化(通过高效液相色谱结合在线串联质谱法定量不同产物评估)需要细胞激活和NO₂⁻;在金属螯合剂、超氧化物歧化酶(SOD)和次卤酸清除剂存在的情况下发生;并被髓过氧化物酶(MPO)抑制剂和过氧化氢酶阻断。在外源性·NO发生器PAPA NONOate(Z - [N - (3 - 氨丙基) - N - (正丙基)氨基]重氮 - 1,2 - 二醇盐)存在下激活的单核细胞通过多种途径促进LDL蛋白质硝化和脂质过氧化。在低·NO通量速率下,蛋白质硝化和脂质过氧化均被过氧化氢酶和过氧化物酶抑制剂抑制,但不受SOD抑制,表明MPO起作用。随着·NO通量速率增加,单核细胞产生的硝基酪氨酸形成以及9 - 羟基 - 10,12 - 十八碳二烯酸/9 - 氢过氧 - 10,12 - 十八碳二烯酸对过氧化氢酶或过氧化物酶抑制剂的存在变得不敏感,但它们越来越受到SOD和蛋氨酸的抑制,表明过氧亚硝酸盐起作用。总体而言,这些结果表明单核细胞利用不同机制产生·NO衍生的氧化剂,并确定MPO是单核细胞中硝化中间体的来源。